Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Endocrinology

Is Multinodular Goiter Hereditary? Who Needs Screening?

At a Glance

Multinodular goiter can cluster in families, but most cases are not caused by an inherited cancer syndrome, so healthy relatives usually do not need routine ultrasound. Symptoms or a family history of medullary thyroid cancer may require prompt evaluation, genetic counseling, and targeted screening.

Yes, multinodular goiters can run in families, but having a family history of goiter does not automatically mean every healthy relative needs a thyroid ultrasound. Ordinary multinodular goiters are very common and are often influenced by environmental factors alongside complex genetics. However, when thyroid nodules are part of a rare inherited thyroid cancer syndrome, targeted screening and genetic counseling become extremely important.

It is essential to distinguish between common familial nodules and rare genetic conditions. Most people with a multinodular goiter do not have an inherited cancer syndrome.

Symptoms vs. Screening: When to See a Doctor Immediately

Before discussing routine screening for healthy family members, it is crucial to understand when a doctor’s evaluation is mandatory. If you or a relative experience any of the following symptoms, you need a clinical neck examination and a likely diagnostic ultrasound immediately, regardless of your family history [1] [2]:

  • A new or rapidly enlarging neck lump
  • Hoarseness or voice changes
  • Difficulty swallowing or breathing
  • Enlarged lymph nodes in the neck
  • A history of significant radiation to the neck during childhood

Routine “screening” refers only to checking relatives who have absolutely no symptoms. If symptoms are present, it is a diagnostic evaluation, not screening.

Ordinary Familial Multinodular Goiter

It is very common for multiple people in the same family to develop a multinodular goiter (an enlarged thyroid gland containing multiple nodules). However, most families with ordinary multinodular goiter do not have a single, identifiable genetic mutation causing the condition [3]. Instead, the development of these goiters is driven by a mix of complex genetics and acquired factors, such as dietary iodine levels [4]. (Note: Because both too much and too little iodine can harm thyroid function, you should never start iodine supplements without discussing it with your clinician).

Because ordinary thyroid nodules are so widespread, routine ultrasound screening for every asymptomatic relative is generally not recommended [5]. Current medical guidelines generally do not advise universal screening for family members because finding small, harmless nodules is extremely common [6]. Unnecessary screening often leads to anxiety, further invasive testing, and biopsies that do not improve long-term health outcomes [7].

Inherited Thyroid Cancer Syndromes

The approach is highly individualized if the family history includes certain types of thyroid cancer or specific genetic syndromes. In these cases, genetic counseling and targeted screening are crucial.

Medullary Thyroid Cancer and MEN2

Medullary thyroid cancer (MTC) is a rare type of thyroid cancer. About one-quarter of MTC cases are hereditary and are caused by mutations in the RET gene, often as part of a syndrome called Multiple Endocrine Neoplasia type 2 (MEN2) [8].

Because of this strong genetic link, clinical guidelines recommend that every person diagnosed with medullary thyroid cancer undergo germline RET genetic testing [8].

  • If a familial mutation is found: Relatives can be offered predictive genetic testing to see if they carry the same mutation. Relatives who test positive need care in a specialist program. Rather than simply relying on ultrasounds and blood tests for calcitonin (a thyroid marker), prophylactic (preventative) thyroid surgery is often recommended early in life, with timing based on the specific mutation and clinical findings [9] [10]. They also require evaluation for other MEN2-related conditions, such as pheochromocytoma (adrenal gland tumors, seen mainly in MEN2A and MEN2B) and hyperparathyroidism (overactive parathyroid glands, seen mainly in MEN2A) [9]. If present, a pheochromocytoma must be managed before any thyroid surgery.
  • Relatives who test negative: A true negative result for a known familial RET mutation means the relative does not have the MEN2-specific risk, sparing them from specialized MEN2 follow-up (though they still carry ordinary population risks for thyroid issues) [11].

(Note: Direct-to-consumer genetic tests are not a substitute for clinical genetics evaluation when MEN2 or other syndromes are suspected).

Familial Nonmedullary Thyroid Cancer (FNMTC)

Familial nonmedullary thyroid cancer is suspected when two or more first-degree relatives (parents, siblings, or children) are diagnosed with common types of thyroid cancer, such as papillary or follicular thyroid cancer [12] [13].

Because these types of thyroid cancer are relatively common, two cases in a family can sometimes occur by chance. Most of these families do not have a single identifiable gene mutation. The benefit of ultrasound screening in these families remains debated and controversial; there is no universally accepted screening schedule, and an endocrinologist will individualize recommendations based on the number of affected relatives and their ages at diagnosis [7].

Rare Genetic Syndromes

Some rare genetic syndromes are known to cause both multinodular goiter and thyroid cancer.

  • DICER1 Syndrome: This rare genetic condition is linked to an increased risk of multinodular goiter and thyroid cancer [14]. While an early-onset goiter or a goiter in a male can be seen, isolated goiter rarely establishes suspicion for DICER1. It is typically considered by a genetics specialist when the family pattern also includes rare characteristic tumors, such as pleuropulmonary blastoma (childhood lung tumors), cystic lung lesions, or ovarian Sertoli-Leydig cell tumors [15]. Known carriers follow syndrome-specific specialist surveillance [16].
  • PTEN Hamartoma Tumor Syndrome (Cowden Syndrome): This syndrome carries a high risk of thyroid cancer and benign thyroid disease [17]. Known carriers require specialist-directed surveillance.

When to Seek Genetic Counseling

If you have a multinodular goiter, it is helpful to gather exact diagnoses (ideally pathology reports) and ages of diagnosis from your relatives. A genetic counselor can help interpret your family tree even if no single-gene test is available.

You should discuss your family history with your doctor or seek an assessment by a genetic counselor if you notice any of these “red flags”:

  • A relative diagnosed with medullary thyroid cancer or MEN2 [8].
  • Multiple first-degree relatives (parents, siblings, or children) diagnosed with thyroid cancer [18].
  • A relative diagnosed with thyroid cancer at an unusually young age [18].
  • A family history of rare tumors or conditions associated with thyroid syndromes (e.g., adrenal tumors, hyperparathyroidism, pleuropulmonary blastoma, or rare ovarian tumors) [9] [15] [19].

If none of these red flags are present and your family members have no symptoms, your family’s multinodular goiter is likely the common, ordinary type, and routine ultrasound screening for healthy relatives is generally not necessary.

Common questions in this guide

Does multinodular goiter run in families?
Yes, multinodular goiter can occur in several members of a family. Usually this reflects a combination of complex genetic influences and environmental factors, such as iodine levels, rather than one inherited mutation or a thyroid cancer syndrome.
Do healthy relatives of someone with multinodular goiter need a thyroid ultrasound?
Usually not if they have no symptoms and the family has ordinary multinodular goiter. Routine ultrasound can find small, harmless nodules that lead to anxiety and invasive testing, but a clinician may recommend targeted screening when the family history includes thyroid cancer or a known inherited syndrome.
What symptoms mean a relative needs prompt thyroid evaluation?
A new or rapidly growing neck lump, hoarseness, trouble swallowing or breathing, or enlarged neck lymph nodes should be evaluated promptly. A history of significant childhood radiation to the neck also warrants medical assessment; the evaluation may include a neck examination and diagnostic ultrasound.
When should a family with thyroid cancer seek genetic counseling?
Genetic counseling is especially important when a relative has medullary thyroid cancer or MEN2, when multiple first-degree relatives have thyroid cancer, or when cancer occurred unusually early. A family history of associated tumors, such as adrenal, parathyroid, childhood lung, or rare ovarian tumors, is also a reason to ask for specialist assessment.
What happens if a family member has a RET mutation?
If a known familial RET mutation is found, relatives can receive predictive testing and those who test positive need specialist care for MEN2-related risks. Depending on the specific mutation and clinical findings, early preventive thyroid surgery may be recommended, along with evaluation for adrenal and parathyroid conditions.
Is ultrasound screening recommended for familial nonmedullary thyroid cancer?
The benefit of ultrasound screening is still debated when relatives have common thyroid cancers such as papillary or follicular cancer. There is no universally accepted schedule, so an endocrinologist usually individualizes recommendations based on the number of affected relatives and their ages at diagnosis.

Get notified when new evidence is published on multinodular goiter.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Sonographic and cytological predictors of thyroid malignancy using TIRADS and Bethesda systems: a cross-sectional study.

    Ahmed Altaee MT, Al-Ani MI, Al-Shammri RJH, Muter MT

    Frontiers in endocrinology 2026; (17()):1804753 doi:10.3389/fendo.2026.1804753.

    PMID: 42109731
  2. 2

    Giant toxic multinodular goiter with dyspnea: A case report.

    Alaguvelsamy S, Pal Singh S, Ramalingam R, Kombupalayam Komarappa Gounder R

    International journal of surgery case reports 2020; (73()):190-195 doi:10.1016/j.ijscr.2020.07.017.

    PMID: 32693233
  3. 3

    Genetic Heterogeneity in Susceptibility to Familial Thyroid Nodular Disease.

    Chong AS, Paschke R, Munté E, et al.

    Thyroid : official journal of the American Thyroid Association 2026; 10507256261485457 doi:10.1177/10507256261485457.

    PMID: 42723469
  4. 4

    Non-Toxic Multinodular Goiter: From Etiopathogenesis to Treatment.

    Unlu MT, Kostek M, Aygun N, et al.

    Sisli Etfal Hastanesi tip bulteni 2022; (56(1)):21-40 doi:10.14744/SEMB.2022.56514.

    PMID: 35515961
  5. 5

    Familial non-medullary thyroid cancer: a critical review.

    Capezzone M, Robenshtok E, Cantara S, Castagna MG

    Journal of endocrinological investigation 2021; (44(5)):943-950 doi:10.1007/s40618-020-01435-x.

    PMID: 33025555
  6. 6

    Family Screening in Familial Papillary Carcinoma: The Early Detection of Thyroid Disease.

    Ríos A, Rodríguez JM, Navas D, et al.

    Annals of surgical oncology 2016; (23(8)):2564-70 doi:10.1245/s10434-016-5149-8.

    PMID: 27020589
  7. 7

    Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.

    El Lakis M, Giannakou A, Nockel PJ, et al.

    Surgery 2019; (165(1)):50-57 doi:10.1016/j.surg.2018.05.075.

    PMID: 30327187
  8. 8

    Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.

    Thomas CM, Asa SL, Ezzat S, et al.

    Current oncology (Toronto, Ont.) 2019; (26(5)):338-344 doi:10.3747/co.26.5539.

    PMID: 31708652
  9. 9

    Hereditary Medullary Thyroid Cancer: Genotype-Phenotype Correlation.

    Frank-Raue K, Raue F

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 2025; (223()):183-209 doi:10.1007/978-3-031-80396-3_7.

    PMID: 40102258
  10. 10

    Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma.

    Raue F, Frank-Raue K

    Journal of the Endocrine Society 2018; (2(8)):933-943 doi:10.1210/js.2018-00178.

    PMID: 30087948
  11. 11

    How has genetics changed the diagnosis and care of multiple endocrine neoplasia type 2? The merits and pitfalls of a genetic-based diagnostic and therapeutic approach.

    Castinetti F, Sahakian N, Romanet P

    Annales d'endocrinologie 2026; (87(3)):102522 doi:10.1016/j.ando.2026.102522.

    PMID: 41866073
  12. 12

    Novel Susceptibility Genes Drive Familial Non-Medullary Thyroid Cancer in a Large Consanguineous Kindred.

    Majdalani P, Yoel U, Nasasra T, et al.

    International journal of molecular sciences 2023; (24(9)) doi:10.3390/ijms24098233.

    PMID: 37175943
  13. 13

    Recognizing Familial Thyroid Neoplasia: The Pathologist's Role in Diagnosis and Management.

    Nosé V, Canberk S, Baloch Z

    Advances in anatomic pathology 2026; (33(4)):291-303 doi:10.1097/PAP.0000000000000543.

    PMID: 42319956
  14. 14

    Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study.

    Khan NE, Bauer AJ, Schultz KAP, et al.

    The Journal of clinical endocrinology and metabolism 2017; (102(5)):1614-1622 doi:10.1210/jc.2016-2954.

    PMID: 28323992
  15. 15

    A family with Sertoli-Leydig cell tumour, multinodular goiter, and DICER1 mutation.

    Haley M, Bindal P, McAuliffe A, Vredenburgh J

    Current oncology (Toronto, Ont.) 2019; (26(3)):183-185 doi:10.3747/co.26.4727.

    PMID: 31285663
  16. 16

    Intrathyroidal Thymus (Incidentaloma) Mimicking Thyroid Neoplasia in DICER1 Syndrome.

    Niedziela M, Sabbaghian N, de Kock L, Foulkes WD

    European thyroid journal 2021; (10(3)):257-261 doi:10.1159/000510004.

    PMID: 34178712
  17. 17

    PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.

    Schultz KAP, Rednam SP, Kamihara J, et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research 2017; (23(12)):e76-e82 doi:10.1158/1078-0432.CCR-17-0629.

    PMID: 28620008
  18. 18

    [Hereditary predispositions to follicular thyroid tumors].

    Decaussin-Petrucci M

    Annales de pathologie 2020; (40(2)):142-147 doi:10.1016/j.annpat.2020.02.011.

    PMID: 32192806
  19. 19

    BROX haploinsufficiency in familial nonmedullary thyroid cancer.

    Pasquali D, Torella A, Accardo G, et al.

    Journal of endocrinological investigation 2021; (44(1)):165-171 doi:10.1007/s40618-020-01286-6.

    PMID: 32385852

This page is for informational purposes only and does not constitute medical advice. Your clinician or a genetic counselor can interpret your family's history and advise whether thyroid evaluation or genetic testing is appropriate.